SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-19-005464
Filing Date
2019-02-28
Accepted
2019-02-28 16:13:49
Documents
3
Period of Report
2019-02-28
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K aimt-8k_20190228.htm 8-K 29511
2 EX-99.1 aimt-ex991_6.htm EX-99.1 267459
3 GRAPHIC gozqggo1y3rg000001.jpg GRAPHIC 8124
  Complete submission text file 0001564590-19-005464.txt   309565
Mailing Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884
Business Address 8000 MARINA BOULEVARD SUITE 300 BRISBANE CA 94005-1884 (650) 614-5220
Aimmune Therapeutics, Inc. (Filer) CIK: 0001631650 (see all company filings)

IRS No.: 452748244 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37519 | Film No.: 19643360
SIC: 2834 Pharmaceutical Preparations